{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[],"dockerImageVersionId":31192,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"‚úÖ Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"üîë Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )\nfrom typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"‚úÖ ADK components imported successfully.\") ","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:42:45.565447Z","iopub.execute_input":"2025-11-15T12:42:45.565764Z","iopub.status.idle":"2025-11-15T12:43:29.982496Z","shell.execute_reply.started":"2025-11-15T12:42:45.565740Z","shell.execute_reply":"2025-11-15T12:43:29.981673Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Gemini API key setup complete.\n‚úÖ ADK components imported successfully.\n","output_type":"stream"}],"execution_count":5},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"‚úÖ Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:43:29.983856Z","iopub.execute_input":"2025-11-15T12:43:29.984424Z","iopub.status.idle":"2025-11-15T12:43:29.993822Z","shell.execute_reply.started":"2025-11-15T12:43:29.984402Z","shell.execute_reply":"2025-11-15T12:43:29.992685Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Helper functions defined.\n","output_type":"stream"}],"execution_count":6},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:43:29.994981Z","iopub.execute_input":"2025-11-15T12:43:29.995855Z","iopub.status.idle":"2025-11-15T12:43:30.081310Z","shell.execute_reply.started":"2025-11-15T12:43:29.995833Z","shell.execute_reply":"2025-11-15T12:43:30.080370Z"}},"outputs":[],"execution_count":7},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"‚úÖ Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:43:30.082177Z","iopub.execute_input":"2025-11-15T12:43:30.082396Z","iopub.status.idle":"2025-11-15T12:43:30.101844Z","shell.execute_reply.started":"2025-11-15T12:43:30.082377Z","shell.execute_reply":"2025-11-15T12:43:30.100940Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":8},{"cell_type":"code","source":"# Run a conversation with two queries in the same session\n# Notice: Both queries are part of the SAME session, so context is maintained\nawait run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:43:30.103817Z","iopub.execute_input":"2025-11-15T12:43:30.104059Z","iopub.status.idle":"2025-11-15T12:43:31.715587Z","shell.execute_reply.started":"2025-11-15T12:43:30.104041Z","shell.execute_reply":"2025-11-15T12:43:31.714525Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":9},{"cell_type":"code","source":"# Run this cell after restarting the kernel. All this history will be gone...\nawait run_session(\n    runner,\n    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n    \"stateful-agentic-session\",\n)  # Note, we are using same session name","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:43:31.716734Z","iopub.execute_input":"2025-11-15T12:43:31.717427Z","iopub.status.idle":"2025-11-15T12:43:32.752915Z","shell.execute_reply.started":"2025-11-15T12:43:31.717396Z","shell.execute_reply":"2025-11-15T12:43:32.751748Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > What did I ask you about earlier?\ngemini-2.5-flash-lite >  You asked me about the capital of the United States and what your name is.\n\nUser > And remind me, what's my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":10},{"cell_type":"code","source":"# Step 1: Create the same agent (notice we use LlmAgent this time)\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"‚úÖ Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:43:32.753764Z","iopub.execute_input":"2025-11-15T12:43:32.753976Z","iopub.status.idle":"2025-11-15T12:43:32.862726Z","shell.execute_reply.started":"2025-11-15T12:43:32.753960Z","shell.execute_reply":"2025-11-15T12:43:32.861755Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":11},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:43:32.863648Z","iopub.execute_input":"2025-11-15T12:43:32.863929Z","iopub.status.idle":"2025-11-15T12:44:35.301653Z","shell.execute_reply.started":"2025-11-15T12:43:32.863904Z","shell.execute_reply":"2025-11-15T12:44:35.300756Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:35.302623Z","iopub.execute_input":"2025-11-15T12:44:35.302875Z","iopub.status.idle":"2025-11-15T12:44:36.258009Z","shell.execute_reply.started":"2025-11-15T12:44:35.302853Z","shell.execute_reply":"2025-11-15T12:44:36.256973Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:36.258839Z","iopub.execute_input":"2025-11-15T12:44:36.259065Z","iopub.status.idle":"2025-11-15T12:44:36.265229Z","shell.execute_reply.started":"2025-11-15T12:44:36.259047Z","shell.execute_reply":"2025-11-15T12:44:36.264465Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of the United States?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"# Re-define our app with Events Compaction enabled\nresearch_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"‚úÖ Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:36.265925Z","iopub.execute_input":"2025-11-15T12:44:36.266131Z","iopub.status.idle":"2025-11-15T12:44:36.284610Z","shell.execute_reply.started":"2025-11-15T12:44:36.266113Z","shell.execute_reply":"2025-11-15T12:44:36.283636Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_48/3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:36.285604Z","iopub.execute_input":"2025-11-15T12:44:36.286167Z","iopub.status.idle":"2025-11-15T12:44:57.374488Z","shell.execute_reply.started":"2025-11-15T12:44:36.286140Z","shell.execute_reply":"2025-11-15T12:44:57.373546Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  The field of AI in healthcare is rapidly evolving, with new developments emerging constantly. Here's a summary of some of the latest and most significant trends and news:\n\n**Key Areas of Advancement:**\n\n*   **Drug Discovery and Development:** This is a major hotbed for AI. Companies are using AI to:\n    *   **Identify potential drug candidates faster:** Machine learning algorithms can analyze vast biological and chemical datasets to predict which molecules are most likely to be effective against specific diseases.\n    *   **Optimize clinical trial design:** AI can help identify suitable patient populations, predict trial outcomes, and even design more efficient trial protocols, potentially reducing costs and timelines.\n    *   **Personalize treatments:** AI can analyze patient genetic data and other factors to identify the most effective drug for an individual, moving towards truly personalized medicine.\n    *   **Examples:** Companies like **Exscientia**, **Atomwise**, and **Recursion Pharmaceuticals** are making significant strides in this area, with some AI-discovered drugs entering clinical trials.\n\n*   **Diagnostic Imaging:** AI continues to revolutionize how medical images (X-rays, CT scans, MRIs, pathology slides) are interpreted:\n    *   **Early disease detection:** AI algorithms can identify subtle patterns indicative of diseases like cancer, diabetic retinopathy, and cardiovascular issues, often before they are noticeable to the human eye.\n    *   **Improved accuracy and efficiency:** AI can assist radiologists and pathologists by flagging suspicious areas, reducing workload, and potentially improving diagnostic accuracy.\n    *   **Examples:** **Google Health** has been a prominent player, and numerous startups are developing AI solutions for specific imaging applications. Regulatory approvals for AI-powered diagnostic tools are becoming more common.\n\n*   **Personalized Medicine and Treatment Planning:** AI is crucial for tailoring treatments to individual patients:\n    *   **Genomic analysis:** AI can process complex genomic data to understand a patient's predisposition to certain diseases or their likely response to specific treatments.\n    *   **Predictive analytics:** AI can forecast disease progression, identify patients at high risk of complications, and suggest proactive interventions.\n    *   **Treatment optimization:** AI can analyze real-world patient data to recommend the best course of treatment based on a vast array of factors.\n\n*   **AI-Powered Virtual Assistants and Chatbots:** These are increasingly being used for:\n    *   **Patient engagement and support:** Providing information, answering FAQs, scheduling appointments, and offering remote monitoring.\n    *   **Clinical workflow optimization:** Assisting healthcare professionals with administrative tasks, retrieving patient information, and summarizing medical records.\n    *   **Mental health support:** Offering accessible and scalable interventions for mental health conditions.\n\n*   **Robotics and AI in Surgery:**\n    *   **Enhanced precision and minimally invasive procedures:** AI is being integrated into robotic surgical systems to improve dexterity, provide real-time guidance, and automate certain repetitive tasks.\n    *   **Pre-operative planning:** AI can analyze imaging data to create detailed surgical plans and simulate procedures.\n\n**Recent News Highlights and Trends:**\n\n*   **Increased Regulatory Scrutiny and Approvals:** As AI in healthcare matures, regulatory bodies like the **FDA** are actively developing frameworks for evaluating and approving AI-powered medical devices and software. We're seeing a growing number of FDA-cleared AI tools.\n*   **Focus on Explainable AI (XAI):** There's a growing demand for AI models that can explain their decision-making process. This is crucial for building trust among clinicians and patients, and for ensuring accountability.\n*   **Data Privacy and Security:** As AI relies on vast amounts of patient data, ensuring its privacy and security remains a paramount concern. Innovations in areas like federated learning and differential privacy are gaining traction.\n*   **AI for Public Health:** AI is being deployed to track disease outbreaks, predict pandemic spread, and optimize public health interventions.\n*   **Ethical Considerations:** Discussions around AI bias, equity, and the responsible deployment of these technologies in healthcare are becoming more prominent.\n\n**Challenges and Future Outlook:**\n\nDespite the rapid progress, challenges remain, including:\n\n*   **Data availability and quality:** Access to diverse, high-quality, and representative datasets is essential for training robust AI models.\n*   **Integration into existing workflows:** Seamlessly integrating AI tools into the complex healthcare ecosystem can be challenging.\n*   **Clinician adoption and trust:** Building confidence and providing adequate training for healthcare professionals is key.\n*   **Cost and accessibility:** Ensuring that AI-powered healthcare solutions are affordable and accessible to all is a critical consideration.\n\nThe future of AI in healthcare is incredibly promising. We can expect to see continued breakthroughs in drug discovery, diagnostics, personalized treatments, and operational efficiency, ultimately leading to better patient outcomes and a more sustainable healthcare system.\n\nTo get the absolute latest news, I recommend checking reputable sources like:\n\n*   **Major medical journals:** *The Lancet*, *NEJM*, *JAMA*.\n*   **Reputable tech news outlets:** *STAT News*, *Fierce Biotech*, *Healthcare IT News*, *MobiHealthNews*.\n*   **Academic conferences and research institutions.**\n*   **Company press releases from leading AI healthcare companies.**\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, there are **very significant and exciting new developments** in AI-driven drug discovery. It's one of the most dynamic areas within AI in healthcare. Here's a breakdown of some key trends and recent advancements:\n\n**1. Accelerated Target Identification and Validation:**\n\n*   **AI for Genomics and Proteomics:** AI algorithms are becoming incredibly adept at sifting through massive datasets of genomic, proteomic, and other biological information to identify novel disease targets (genes, proteins) that were previously unknown or difficult to pinpoint.\n*   **Predicting Protein Structures:** Tools like **AlphaFold** (from DeepMind) have revolutionized protein structure prediction. Knowing the 3D structure of a protein is crucial for understanding its function and designing drugs that can bind to it. This has dramatically accelerated the ability to identify and validate potential drug targets.\n\n**2. Enhanced Small Molecule and Biologics Design:**\n\n*   **Generative AI for Molecule Design:** This is a major breakthrough. Instead of just screening existing libraries, AI models can now **generate novel molecular structures** from scratch that are optimized for specific properties, such as binding affinity to a target, solubility, and low toxicity. This allows for the exploration of chemical space that was previously inaccessible.\n*   **De Novo Design:** AI is moving beyond simply modifying existing drugs to designing entirely new molecules tailored to specific diseases.\n*   **AI for Antibody Discovery:** Similar generative approaches are being used to design novel antibodies and other biologics with improved therapeutic properties.\n\n**3. Revolutionizing Preclinical Testing and Optimization:**\n\n*   **In Silico (Computer Simulation) Testing:** AI is reducing the need for extensive and costly wet-lab experiments. Models can predict:\n    *   **Drug efficacy:** How well a potential drug will work against a target.\n    *   **ADMET properties:** Absorption, distribution, metabolism, excretion, and toxicity. This helps weed out problematic drug candidates early on.\n    *   **Drug interactions:** Predicting how a new drug might interact with existing medications.\n*   **Optimizing Drug Formulations:** AI can help determine the best way to formulate a drug for optimal delivery and stability.\n\n**4. Smarter Clinical Trial Design and Patient Stratification:**\n\n*   **Identifying Optimal Patient Populations:** AI can analyze patient data to identify subgroups that are most likely to respond to a particular drug, leading to more successful and efficient clinical trials.\n*   **Predicting Trial Success:** AI models are being developed to predict the likelihood of success for a given clinical trial, allowing companies to prioritize their investments.\n*   **Virtual Trials and Digital Twins:** While still emerging, the concept of using AI to create \"digital twins\" of patients or entire populations for virtual drug testing is a frontier being actively explored.\n\n**5. Companies and Recent Progress:**\n\nMany companies are at the forefront, and here are a few examples of notable progress:\n\n*   **Exscientia:** Known for using AI to design molecules and has had several AI-designed drugs enter clinical trials. They recently announced advancements in their platform.\n*   **Recursion Pharmaceuticals:** Uses AI and automation to map human cell biology and discover new treatments. They have a growing pipeline of drug candidates.\n*   **Atomwise:** Specializes in using deep learning for small molecule drug discovery, often partnering with other pharma companies.\n*   **Insilico Medicine:** Gained attention for its end-to-end AI platform that discovered and advanced a drug candidate for Idiopathic Pulmonary Fibrosis into clinical trials in a remarkably short timeframe.\n*   **DeepMind (Alphabet):** While not a drug discovery company per se, their foundational work on **AlphaFold** has had a seismic impact on the entire field by providing accurate protein structure predictions.\n\n**Key Takeaways for Drug Discovery:**\n\n*   **Speed:** AI is drastically shortening the time it takes to identify targets and design potential drug candidates.\n*   **Efficiency:** AI helps reduce the number of failed experiments and costly late-stage failures.\n*   **Novelty:** AI is enabling the discovery of entirely new classes of molecules and therapeutic approaches.\n*   **Precision:** AI is moving towards highly personalized drug discovery, tailoring treatments to specific patient profiles.\n\nThe pace of innovation here is astounding, and it's transforming the pharmaceutical industry from a historically long and expensive process to a more agile and data-driven one.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're asking about the **\"Enhanced Small Molecule and Biologics Design\"** development in AI-driven drug discovery. This is indeed a very exciting area because it represents a shift from *finding* existing solutions to *creating* entirely new ones.\n\nLet's dive deeper into what this entails:\n\n**The Core Idea: Generative AI for Molecular Design**\n\nTraditionally, drug discovery often involved:\n1.  **Target Identification:** Finding a biological molecule (like a protein) that's implicated in a disease.\n2.  **Screening:** Testing vast libraries of existing chemical compounds (millions, even billions) to see if any bind to and affect the target. This is like searching for a specific key in a massive warehouse full of pre-made keys.\n3.  **Optimization:** Taking a \"hit\" compound and tweaking its structure to improve its efficacy, reduce side effects, and enhance its pharmacokinetic properties.\n\nGenerative AI flips this on its head by acting like a highly skilled chemist who can design a custom key from scratch, optimized for a specific lock.\n\n**How it Works (Simplified):**\n\n1.  **Training the AI:** Generative AI models (often based on deep learning architectures like Generative Adversarial Networks - GANs, Variational Autoencoders - VAEs, or Transformer models) are trained on enormous datasets of known molecules. This training teaches them the \"rules\" of chemistry: how atoms bond, what molecular shapes are stable, and what properties are associated with different structures.\n2.  **Defining the Target Properties:** Researchers tell the AI what they're looking for. This can include:\n    *   **Binding Affinity:** How strongly the generated molecule should bind to a specific protein target.\n    *   **Selectivity:** Ensuring it only binds to the intended target and not others (to avoid side effects).\n    *   **ADMET Properties:** Predicting solubility, oral bioavailability, metabolic stability, and potential toxicity.\n    *   **Synthesizability:** Designing molecules that can actually be made in a lab.\n3.  **Generating Novel Molecules:** The AI then uses its learned knowledge to generate entirely new molecular structures that are predicted to possess the desired properties. It's not just random; it's a directed, intelligent design process.\n4.  **Validation:** These AI-generated \"de novo\" (from scratch) molecules are then synthesized and tested experimentally in the lab to confirm their predicted properties.\n\n**Key Advancements and Nuances:**\n\n*   **De Novo Design:** This is the term for creating molecules without relying on pre-existing structures. AI's ability to explore uncharted chemical space means it can discover molecules with novel mechanisms of action that might have been missed by traditional screening methods.\n*   **Multi-Objective Optimization:** Designing drugs is complex because you often have conflicting goals. For example, a molecule might be highly potent but also toxic, or very stable but poorly soluble. Generative AI models can be trained to balance these multiple objectives simultaneously, finding molecules that represent the best possible compromise.\n*   **Tailoring to Specific Targets and Diseases:**\n    *   **Small Molecules:** These are typically small organic compounds taken orally (like aspirin or ibuprofen). AI is highly effective at designing novel small molecules that can inhibit or activate specific protein targets within cells.\n    *   **Biologics (e.g., Antibodies, Peptides):** While more complex, AI is also being applied to design novel antibodies, antibody-drug conjugates, and therapeutic peptides. This involves designing protein sequences and structures that can target extracellular proteins or even cellular receptors.\n*   **Accelerated Discovery Cycles:** By automating the early stages of design and prediction, AI significantly speeds up the timeline from initial idea to a promising drug candidate ready for further testing.\n\n**Why is this a Game-Changer?**\n\n*   **Unlocking Novel Therapeutics:** AI can explore vast and complex chemical landscapes that are beyond human intuition or computational brute force. This leads to the discovery of truly novel drug candidates with potentially superior properties.\n*   **Overcoming \"Druggability\" Challenges:** Many disease targets are considered \"undruggable\" because they lack well-defined binding pockets or are difficult to modulate with existing chemical classes. Generative AI can help overcome these challenges by designing molecules that can interact with these difficult targets.\n*   **Personalized Drug Design:** In the future, generative AI could potentially design drugs tailored not just to a disease but to an individual patient's specific genetic makeup or disease subtype.\n\nIn essence, generative AI in drug design is about moving from a \"hunting\" paradigm to a \"creation\" paradigm, making the process of finding new medicines more intelligent, efficient, and ultimately, more successful.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  The landscape of companies involved in AI-driven drug discovery, particularly in the area of **enhanced small molecule and biologics design**, is dynamic and growing. It includes a mix of established pharmaceutical giants, dedicated AI biotech startups, and technology providers.\n\nHere are some of the key players and categories of companies involved:\n\n**1. AI-Native Biotech Companies (Often Focused on Generative Design):**\n\nThese companies were founded with AI at their core, often leveraging generative models for drug design.\n\n*   **Insilico Medicine:** As mentioned before, they've been very prominent for their end-to-end AI platform that handles target discovery, molecule generation, and preclinical development. They have a strong focus on generative chemistry.\n*   **Exscientia:** A leader in using AI for drug design, they have multiple AI-designed molecules in clinical trials. They focus on both small molecules and biologics and have extensive partnerships.\n*   **Recursion Pharmaceuticals:** While their platform is broader (mapping human cell biology), their ability to identify novel targets and then design compounds to interact with them places them firmly in this category.\n*   **Atomwise:** A pioneer in using deep learning for small molecule drug discovery, particularly for structure-based design and virtual screening, which can inform generative efforts.\n*   **Schr√∂dinger:** While also a long-standing computational chemistry company, Schr√∂dinger has heavily invested in AI and machine learning to enhance its existing simulation platforms for drug design, including generative capabilities.\n*   **Verb Biologics:** Focuses on AI-driven design of antibody-drug conjugates (ADCs) and other biologics.\n*   **Relay Therapeutics:** Employs a physics-based and AI-driven approach to understand protein motion and design therapeutics.\n*   **Absci:** Uses AI to design and discover novel antibody therapeutics, with a focus on generative models for antibody sequences.\n\n**2. Established Pharmaceutical Companies (Acquiring, Partnering, or Developing In-House AI Capabilities):**\n\nMajor pharma companies are rapidly integrating AI into their R&D. Many are doing this through:\n\n*   **Partnerships and Acquisitions:** Collaborating with or acquiring AI biotech startups.\n*   **In-House AI Teams:** Building their own internal AI R&D departments.\n*   **Examples (not exhaustive, but influential):**\n    *   **Pfizer:** Has numerous AI initiatives and partnerships across its R&D.\n    *   **Novartis:** Actively uses AI and machine learning for target identification and drug design.\n    *   **Gilead Sciences:** Leverages AI for various aspects of drug discovery.\n    *   **Merck:** Investing in AI for faster drug discovery and development.\n    *   **AstraZeneca:** Has a strong focus on data science and AI in its research.\n    *   **Johnson & Johnson:** Utilizing AI across its pharmaceutical R&D pipeline.\n    *   **Roche/Genentech:** Known for its strong computational biology and AI efforts.\n\n**3. Technology and Cloud Providers:**\n\nThese companies provide the underlying infrastructure, AI models, and platforms that enable drug discovery companies to operate.\n\n*   **NVIDIA:** Provides powerful GPUs essential for training complex AI models and has developed specialized software (like Clara Discovery) for drug discovery applications.\n*   **Google Cloud / AWS / Microsoft Azure:** Offer scalable cloud computing resources and AI/ML tools that many drug discovery companies utilize.\n*   **DeepMind (Alphabet):** As mentioned, their **AlphaFold** has been a foundational technology, enabling many companies to better understand protein targets for design. They continue to explore other biological applications of AI.\n\n**4. Specialized AI/ML Software and Platform Providers:**\n\nThese companies offer specific AI tools or platforms that can be licensed or used to augment existing R&D efforts.\n\n*   **Cerebras Systems:** Develops specialized AI hardware (Wafer Scale Engine) optimized for large AI models, which can be applied to drug discovery.\n*   **Tempus:** While more focused on precision medicine and clinical data, their extensive datasets and AI capabilities can inform drug discovery.\n\n**Key Trends Driving This Landscape:**\n\n*   **Partnerships are Crucial:** Many smaller AI biotechs lack the resources for full-scale clinical development and manufacturing, making partnerships with large pharma essential for bringing drugs to market.\n*   **Data is King:** Companies with access to large, high-quality biological and chemical datasets have a significant advantage.\n*   **Interdisciplinary Teams:** Success requires a blend of expertise in AI/machine learning, chemistry, biology, pharmacology, and data science.\n\nThis is a rapidly evolving space, with new players emerging and existing ones forging new collaborations. The focus is increasingly on how AI can not just speed up existing processes but enable entirely new ways of discovering and designing medicines.\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\n‚úÖ SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\n‚ùå No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:57.375373Z","iopub.execute_input":"2025-11-15T12:44:57.375608Z","iopub.status.idle":"2025-11-15T12:44:57.389897Z","shell.execute_reply.started":"2025-11-15T12:44:57.375589Z","shell.execute_reply":"2025-11-15T12:44:57.388765Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\n‚úÖ SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='553018df-3330-40f8-817f-8dff3973f4f9' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1763210676.326867, 'end_timestamp': 1763210685.77724, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': 'The conversation is about the latest advancements in AI in healthcare, specifically focusing on drug discovery.\\n\\n**Key Information and Decisions Made:**\\n\\n*   The AI agent provided a comprehensive overview of AI in healthcare, highlighting key areas of advancement like drug discovery, diagnostic imaging, personalized medicine, virtual assistants, and robotics.\\n*   The user then specifically asked for more details on AI in drug discovery.\\n*   The AI agent elaborated on several key trends in AI-driven drug discovery:\\n    *   Accelerated target identification and validation (e.g., using AI for genomics/proteomics, protein structure prediction like AlphaFold).\\n    *   **Enhanced small molecule and biologics design (this was the focus of the second user query).**\\n    *   Revolutionized preclinical testing and optimization (in silico testing, ADMET prediction).\\n    *   Smarter clinical trial design and patient stratification.\\n*   The user then requested more information specifically about the \"Enhanced Small Molecule and Biologics Design\" development.\\n*   The AI agent explained this concept in detail, emphasizing the role of **Generative AI** in creating novel molecular structures from scratch, rather than just screening existing libraries.\\n    *   It described how these models are trained on chemical data to understand molecular rules.\\n    *   It outlined the process of defining target properties (binding affinity, selectivity, ADMET, synthesizability) and the AI generating molecules accordingly.\\n    *   The explanation highlighted \"De Novo Design,\" multi-objective optimization, and the application to both small molecules and biologics.\\n    *   The significance of this advancement was emphasized as enabling the discovery of novel therapeutics, overcoming \"druggability\" challenges, and paving the way for personalized drug design.\\n\\n**Unresolved Questions or Tasks:**\\n\\nThere are no outstanding questions or tasks. The user received detailed explanations on their queries. The conversation ended with the AI agent providing a thorough explanation of generative AI in drug design.', 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='008494ff-e25d-4ce2-8a68-7ca630121d3a' timestamp=1763210693.645292\n","output_type":"stream"}],"execution_count":17},{"cell_type":"code","source":"# Define scope levels for state keys (following best practices)\nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"‚úÖ Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:57.390899Z","iopub.execute_input":"2025-11-15T12:44:57.391263Z","iopub.status.idle":"2025-11-15T12:44:57.407392Z","shell.execute_reply.started":"2025-11-15T12:44:57.391242Z","shell.execute_reply":"2025-11-15T12:44:57.406526Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Tools created.\n","output_type":"stream"}],"execution_count":18},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"‚úÖ Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:57.408415Z","iopub.execute_input":"2025-11-15T12:44:57.408741Z","iopub.status.idle":"2025-11-15T12:44:57.424755Z","shell.execute_reply.started":"2025-11-15T12:44:57.408714Z","shell.execute_reply":"2025-11-15T12:44:57.423896Z"}},"outputs":[{"name":"stdout","text":"‚úÖ Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":19},{"cell_type":"code","source":"# Retrieve the session and inspect its state\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nüîç Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:57.425911Z","iopub.execute_input":"2025-11-15T12:44:57.426211Z","iopub.status.idle":"2025-11-15T12:44:57.554178Z","shell.execute_reply.started":"2025-11-15T12:44:57.426186Z","shell.execute_reply":"2025-11-15T12:44:57.553013Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n","output_type":"stream"},{"traceback":["\u001b[0;31m---------------------------------------------------------------------------\u001b[0m","\u001b[0;31mAttributeError\u001b[0m                            Traceback (most recent call last)","\u001b[0;32m/tmp/ipykernel_48/427223363.py\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      5\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      6\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"Session State Contents:\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 7\u001b[0;31m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0msession\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mstate\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m      8\u001b[0m \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"\\nüîç Notice the 'user:name' and 'user:country' keys storing our data!\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n","\u001b[0;31mAttributeError\u001b[0m: 'NoneType' object has no attribute 'state'"],"ename":"AttributeError","evalue":"'NoneType' object has no attribute 'state'","output_type":"error"}],"execution_count":20},{"cell_type":"code","source":"# Start a completely new session - the agent won't know our name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n\n# Expected: The agent won't know the name because this is a different session","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:57.554642Z","iopub.status.idle":"2025-11-15T12:44:57.554939Z","shell.execute_reply.started":"2025-11-15T12:44:57.554812Z","shell.execute_reply":"2025-11-15T12:44:57.554824Z"}},"outputs":[],"execution_count":null},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)\n\n# Note: Depending on implementation, you might see shared state here.\n# This is where the distinction between session-specific and user-specific state becomes important.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:57.556280Z","iopub.status.idle":"2025-11-15T12:44:57.556565Z","shell.execute_reply.started":"2025-11-15T12:44:57.556435Z","shell.execute_reply":"2025-11-15T12:44:57.556448Z"}},"outputs":[],"execution_count":null},{"cell_type":"code","source":"# Clean up any existing database to start fresh (if Notebook is restarted)\nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"‚úÖ Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-15T12:44:57.557335Z","iopub.status.idle":"2025-11-15T12:44:57.557577Z","shell.execute_reply.started":"2025-11-15T12:44:57.557459Z","shell.execute_reply":"2025-11-15T12:44:57.557469Z"}},"outputs":[],"execution_count":null},{"cell_type":"code","source":"","metadata":{"trusted":true},"outputs":[],"execution_count":null}]}